Abound Wealth Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402 Hold
6
﹤0.01% 983
2026
Q1
$458 Hold
6
﹤0.01% 1065
2025
Q4
$383 Hold
6
﹤0.01% 984
2025
Q3
$379 Hold
6
﹤0.01% 960
2025
Q2
$448 Hold
6
﹤0.01% 874
2025
Q1
$529 Hold
6
﹤0.01% 816
2024
Q4
$548 Sell
6
-10
-63% -$1.02K ﹤0.01% 788
2024
Q3
$1.79K Hold
16
﹤0.01% 723
2024
Q2
$1.57K Hold
16
﹤0.01% 668
2024
Q1
$1.6K Buy
16
+1
+7% +$88 ﹤0.01% 708
2023
Q4
$1.35K Sell
15
-5
-25% -$399 ﹤0.01% 719
2023
Q3
$1.53K Hold
20
﹤0.01% 653
2023
Q2
$1.68K Hold
20
﹤0.01% 662
2023
Q1
$1.69K Hold
20
﹤0.01% 603
2022
Q4
$1.63K Hold
20
﹤0.01% 565
2022
Q3
$1.42K Buy
+20
New +$1.8K ﹤0.01% 541

Other funds holding EMN

Abound Wealth Management's EMN Position: Q2 2026 in Review

Abound Wealth Management held its Eastman Chemical (EMN) position steady in Q2 2026 at 6 shares worth $402. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Abound Wealth Management first reported a position in EMN in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.79K in Q3 2024. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Abound Wealth Management held 6 shares of Eastman Chemical worth $402 as of Q2 2026.
  • Abound Wealth Management left its Eastman Chemical share count unchanged in Q2 2026.
  • Eastman Chemical made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #983 holding.
  • Abound Wealth Management first reported a position in Eastman Chemical in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Eastman Chemical position peaked at $1.79K in Q3 2024.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.